72 results
Page 2 of 4
8-K
EX-99.1
p5dbhiqs2lrbtyf o4w
12 May 22
Immunome Reports First Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
1lwi4j6c7f
28 Mar 22
Immunome Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
EX-99.1
on4y8u0vr
11 Mar 22
FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
2:33pm
8-K
EX-99.1
82ndt s2ei
8 Feb 22
Other Events
8:27am
8-K
EX-99.1
2ayda0i k4xd8hf49bd5
10 Jan 22
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
4:52pm
8-K
EX-99.1
ei8rn 1ayuyyd6qm
29 Nov 21
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
7:14am
8-K
56f52z zg
18 Oct 21
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
75jdu1bi03 5i85lgtqx
18 Oct 21
Regulation FD Disclosure
4:27pm
8-K
kihx gat0
21 Sep 21
Regulation FD Disclosure
7:40am
8-K
EX-99.1
1onfot328 e0v939u8j9
21 Sep 21
Regulation FD Disclosure
7:40am
8-K
zxdlkpw7 t96
8 Sep 21
Other Events
4:55pm
8-K
EX-99.1
ku4c0m1onmvx
8 Sep 21
Other Events
4:55pm
8-K
n3ktctznmajcfo4c
5 Aug 21
Departure of Directors or Certain Officers
4:36pm
8-K
EX-10.1
jtx5 lw9vc9r66
5 Aug 21
Departure of Directors or Certain Officers
4:36pm
8-K
EX-99.1
wi9ovn q9sowjerq1f3
20 Jul 21
Regulation FD Disclosure
8:36am